MiR-421 Promotes Lipid Metabolism by Targeting PTEN Via Activating PI3K/AKT/mTOR Pathway in Non-Small Cell Lung Cancer

References

• Herbst RS , MorgenszternD , BoshoffC. The biology and management of non-small cell lung cancer. Nature553(7689), 446–454 (2018).
   PubMed Web of Science ®Google Scholar
• Burdett S , RydzewskaL , TierneyJet al. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst. Rev.10, CD002142 (2016).
   PubMedGoogle Scholar
• Ko EC , RabenD , FormentiSC. The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer. Clin. Cancer Res.24(23), 5792–5806 (2018).
   PubMed Web of Science ®Google Scholar
• Huang Q , WangQ , LiDet al. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer. J. Exp. Clin. Cancer Res.38(1), 129 (2019).
   PubMedGoogle Scholar
• Kimura I , IchimuraA , Ohue-KitanoR , IgarashiM. Free fatty acid receptors in health and disease. Physiol. Rev.100(1), 171–210 (2020).
   PubMed Web of Science ®Google Scholar
• Ventura R , MordecK , WaszczukJ. Inhibition of de novo palmitate synthesis by fatty acid synthase induces apoptosis in tumor cells by remodeling cell membranes, inhibiting signaling pathways, and reprogramming gene expression. EBioMedicine2(8), 808–24 (2015).
   PubMed Web of Science ®Google Scholar
• Ali A , LevantiniE , TeoJTet al. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol. Med.10(3), e8313 (2018).
   PubMed Web of Science ®Google Scholar
• Zhou L , ZhengSJ. The roles of microRNAs (miRNAs) in avian response to viral infection and pathogenesis of Avian immunosuppressive disease. Int. J. Mol. Sci.20(21), 5454 (2019).
   PubMed Web of Science ®Google Scholar
• John A , KubosumiA , ReddyPH. Mitochondrial microRNAs in aging and neurodegenerative diseases. Cells9(6), 1345 (2020).
   PubMed Web of Science ®Google Scholar
• Wu Y , CrawfordM , YuB , MaoY , Nana-SinkamSP , LeeLJ. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol. Pharm.8(4), 1381–9 (2011).
   PubMed Web of Science ®Google Scholar
• Toda H , SekiN , KurozumiSet al. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis. Mol. Oncol.14(2), 426–446 (2020).
   PubMed Web of Science ®Google Scholar
• Li Q , LiB , LiQet al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis.9(9), 854 (2018).
   PubMedGoogle Scholar
• Chu B , WuT , MiaoL , MeiY , WuM. MiR-181a regulates lipid metabolism via IDH1. Sci. Rep.5, 8801 (2015).
   PubMed Web of Science ®Google Scholar
• Cruz-Gil S , Sanchez-MartinezR , Gomezde Cedron Met al. Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 rol. J. Lipid Res.59(1), 14–24 (2018).
   PubMed Web of Science ®Google Scholar
• Duan FG , WangMF , CaoYBet al. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer. Cell Death Dis.10(11), 821 (2019).
   PubMedGoogle Scholar
• Rulle U , TsourtiZ , CasanovaRet al. Computer-based intensity measurement assists pathologists in scoring phosphatase and tensin homolog immunohistochemistry – clinical associations in NSCLC patients of the European Thoracic Oncology Platform Lungscape Cohort. J. Thorac. Oncol.13(12), 1851–1863 (2018).
   PubMed Web of Science ®Google Scholar
• Akca H , DemirayA , AslanM , AcikbasI , TokgunO. Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines. J. Enzyme Inhib. Med. Chem.28(3), 539–44 (2013).
   PubMed Web of Science ®Google Scholar
• Bu W , LuoT. miR-1297 Promotes cell proliferation of non-small cell lung cancer cells: involving in PTEN/Akt/Skp2 signaling pathway. DNA Cell Biol.36(11), 976–982 (2017).
   PubMed Web of Science ®Google Scholar
• Liao Z , ZhengQ , WeiTet al. MicroRNA-561 affects proliferation and cell cycle transition through PTEN/AKT signaling pathway by targeting P-REX2a in NSCLC. Oncol. Res.28(2), 147–159 (2020).
   PubMed Web of Science ®Google Scholar
• Li B , ZhangJ , SuYet al. Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism. Mol. Med. Rep.20(4), 3793–3801 (2019).
   PubMed Web of Science ®Google Scholar
• Li Q , YangJ , YuQet al. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. Clin. Cancer Res.19(22), 6252–60 (2013).
   PubMed Web of Science ®Google Scholar
• Chen J , ChenJ , HuangJet al. HIF-2alpha upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway. Aging (Albany NY)11(23), 10839–10860 (2019).
   PubMedGoogle Scholar
• Reck M , RabeKF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N. Engl. J. Med.377(9), 849–861 (2017).
   PubMed Web of Science ®Google Scholar
• Huang C , FreterC. Lipid metabolism, apoptosis and cancer therapy. Int. J. Mol. Sci.16(1), 924–49 (2015).
   PubMed Web of Science ®Google Scholar
• Gomez de Cedron M , Ramirezde Molina A. Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. J. Lipid Res.57(2), 193–206 (2016).
   PubMed Web of Science ®Google Scholar
• Kasomva K , SenA , PaulrajMGet al. Roles of microRNA in prostate cancer cell metabolism. Int. J. Biochem. Cell Biol.102, 109–116(2018).
   PubMed Web of Science ®Google Scholar
• Ren Z , HeM , ShenTet al. MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression. Cancer Biol. Ther.21(3), 231–240 (2020).
   PubMed Web of Science ®Google Scholar
• Cheng L , ZhuY , HanHet al. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death Dis.8(7), e2916 (2017).
   PubMedGoogle Scholar
• Gharib E , NasriNasrabadi P , RezaZali M. miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism. J. Cell Physiol.235(7–8), 5570–5589 (2020).
   PubMed Web of Science ®Google Scholar
• Koufaris C , ValbuenaGN , PomyenYet al. Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells. Oncogene35(21), 2766–76 (2016).
   PubMed Web of Science ®Google Scholar
• Yuan Y , LiaoH , PuQet al. miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer. Signal Transduct Target Ther.5(1), 85 (2020).
   PubMed Web of Science ®Google Scholar
• Clement S , SobolewskiC , GomesDet al. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein. Liver Int.39(7), 1226–1236 (2019).
   PubMed Web of Science ®Google Scholar
• Gao M , LiuD. CRISPR/Cas9-based Pten knock-out and sleeping beauty transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice. Cancer Biol. Ther18(7), 505–512 (2017).
   PubMed Web of Science ®Google Scholar
• Haddadi N , LinY , TravisG , SimpsonAM , NassifNT , McGowanEM. PTEN/PTENP1: ‘regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy. Mol. Cancer17(1), 37 (2018).
   PubMedGoogle Scholar
• Yue S , LiJ , LeeSYet al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab.19(3), 393–406 (2014).
   PubMed Web of Science ®Google Scholar
• Ling C , WangX , ZhuJet al. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer. Cancer Med.8(7), 3520–3531 (2019).
   PubMed Web of Science ®Google Scholar
• Li J , ZhouZ , XuFCet al. MicroRNA-374b accelerates the development of lung cancer through downregulating PTEN expression via activating PI3K/Akt pathway. Eur. Rev. Med. Pharmacol Sci.23(3), 1116–1124 (2019).
   PubMed Web of Science ®Google Scholar
• Ghanavat M , ShahrouzianM , DerisZayeri Z , BanihashemiS , KazemiSM , SakiN. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci.264, 118603 (2021).
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab AF , MahmoudW , Al-HarizyRM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol. Res.150, 104511 (2019).
   PubMed Web of Science ®Google Scholar
• Zhai S , ZhaoL , LinT , WangW. Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth. J. Cell Biochem.120(4), 6651–6660 (2019).
   PubMed Web of Science ®Google Scholar
• Dai Q , LiN , ZhouX. Increased miR-21a provides metabolic advantages through suppression of FBP1 expression in non-small cell lung cancer cells. Am. J. Cancer Res.7(11), 2121–2130 (2017).
   PubMed Web of Science ®Google Scholar
• Liu L , CuiS , ZhangR , ShiY , LuoL. MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D. Am. J. Cancer Res.7(4), 857–868 (2017).
   PubMed Web of Science ®Google Scholar